Antibiotic resistance is a major issue in the treatment of infectious diseases such as tuberculosis. Existing antibiotics target only a few cellular pathways and there is an urgent need for antibiotics that have novel molecular mechanisms. The glmU gene is essential in Mycobacterium tuberculosis, being required for optimal bacterial growth, and has been selected as a possible drug target for structural and functional investigation. GlmU is a bifunctional acetyltransferase/uridyltransferase that catalyses the formation of UDP-GlcNAc from GlcN-1-P. UDP-GlcNAc is a substrate for two important biosynthetic pathways: lipopolysaccharide and peptidoglycan synthesis. The crystal structure of M. tuberculosis GlmU has been determined in an unliganded form and in complex with GlcNAc-1-P or UDP-GlcNAc. The structures reveal the residues that are responsible for substrate binding. Enzyme activities were characterized by 1 H NMR and suggest that the presence of acetyl-coenzyme A has an inhibitory effect on uridyltransferase activity.
Introduction
The general metabolic route for the incorporation of sugar units into structural polysaccharides involves the conversion of sugars to sugar nucleotides (Frey, 1996; Slawomir et al., 2006) . In prokaryotic cells, the sugar nucleotide UDP-Nacetyl-d-glucosamine (UDP-GlcNAc) is synthesized from fructose-6-phosphate (Fru-6-P) in four steps by three different enzymes (Slawomir et al., 2006; Mengin-Lecreulx & van Heijenoort, 1993) . Fructose-6-phophate is first converted to glucosamine-6-phosphate (GlcN-6-P) by d-fructose-6phosphate aminotransferase (GlmS), utilizing l-glutamine. GlcN-6-P is then isomerized to glucosamine-1-phosphate (GlcN-1-P) by the enzyme phosphoglucosamine mutase. The last two steps of the reaction are catalyzed by the bifunctional enzyme GlmU, which has acetyltransferase and uridyltransferase activity, to form UDP-GlcNAc (Mengin-Lecreulx & van Heijenoort, 1994) . In contrast, in eukaryotic cells each step of the pathway is catalyzed by a separate enzyme (Slawomir et al., 2006) .
The final product of GlmU, UDP-GlcNAc, is a substrate for two important biosynthetic pathways: peptidoglycan and lipid A synthesis (Slawomir et al., 2006; Mengin-Lecreulx & van Heijenoort, 1993) . Lipid A is the major component of the outer monolayer of the outer membranes of most Gramnegative bacteria and provides hydrophobic anchoring for lipopolysaccharides (Anderson & Raetz, 1987) . Peptidoglycan polymers are cross-linked through short peptides and penicillin-binding proteins (PBPs), generating the net-like three-dimensional structure of the cell wall (Walsh & Bugg, 1992; Brennan & Nikaido, 1995) . Many antibiotics target this cell-wall synthesis machinery, including the -lactams, vancomycin, fosfomycin, nisin and bacitracin (Walsh & Bugg, 1992) . GlmU is also involved in the synthesis of the -1,6-N-acetyld-glucosamine polysaccharide adhesin, which is required for biofilm formation in Escherichia coli and Staphylococcus epidermidis, and GlmU inhibitors have shown strong antibiofilm activity on urinary catheters (Burton et al., 2006) . E. coli GlmU (EcGlmU) loses acetyltransferase activity in the absence of thiol-reducing agents (Pompeo et al., 1998) and the best-known inhibitors of GlmU are thiol-specific reagents such as iodoacetamide (IDA) and N-substituted maleimides, which include N-ethylmaleimide (NEM), N-phenylmaleimide, N,N 0 -(1,2-phenylene)dimaleimide (oPDM) and N-(1-pyrenyl)maleimide (PyrM) (Burton et al., 2006) .
The gene glmU has been identified as essential for optimal growth of M. tuberculosis (Sassetti et al., 2003) and is not present in humans; hence, it is of interest as a drug-design target. To this end, the crystal structures of GlmU from E. coli, Streptococcus pneumoniae and Haemophilus influenzae have been determined (Brown et al., 1999; Kostrewa et al., 2001; Mochalkin et al., 2007) . These trimeric protein structures show a C-terminal left-handed -helix domain that catalyzes the synthesis of N-acetylglucosamine-1-phosphate (GlcNAc-1-P) from GlcN-1-P and acetyl coenzyme A (acetyl CoA),
The N-terminal pyrophosphatase (PPase) domain displays a Rossmann fold and catalyzes the formation of UDP-GlcNAc from GlcNAc-1-P (produced by the C-terminal domain) and UTP,
Although GlmU has been crystallized from several species and in a variety of forms, no crystal structure is available with the substrate GlcNAc-1-P in the uridyltransferase active site, leading to uncertainty concerning the protein-substrate contacts and the chemical mechanism of the uridyltransferase reaction. Here, we report the structures of M. tuberculosis GlmU (MtGlmU) in an unliganded form and in complexes in which either GlcNAc-1-P or UDP-GlcNAc occupies the uridyltransferase active site. These structures identify the active-site contacts between protein and ligands and suggest a ternary-complex mechanism of action for the GlmU uridyltransferase reaction. Enzyme assays for both GlmU reactions commonly use radio-labelled substrates: [ 14 C]-acetyl-CoA for study of acetyltransferase activity and [ 14 C]-GlcNAc-1-P for study of uridyltransferase activity. Here, we describe a novel 1 H NMR methodology for characterizing the enzymatic activities of MtGlmU. The NMR assays suggest an inhibitory effect for acetyl-CoA on the acetyltransferase reaction.
Materials and methods

Expression and purification
The glmU gene was amplified from M. tuberculosis genomic DNA by PCR using the primers 5 0 -GGCAGCGGCGCGAT-GACGTTTCCTGGTGACAC-3 0 and 5 0 -GAAAGCTGGGT-GTCACGGTGTCTGATCAGC-3 0 . The construct was cloned into the pDEST17 N-terminal His 6 -tag vector (Invitrogen) using Gateway cloning. Protein was overexpressed in E. coli BL21(DE3) cell strain using an autoinduction protocol (Studier, 2005 ). An overnight culture was prepared by inoculating 5 ml PA-0.5G medium supplemented with ampicillin (100 mg l À1 ) and incubating at 310 K with shaking (160 rev min À1 ). Overnight cultures were transferred into 1 l ZYP-5052 medium and incubated at 310 K with shaking at 160 rev min À1 . On reaching an OD 600 of 0.7 (approximately 4 h), the cell culture was cooled to 277 K for 1 h. The culture was then incubated for approximately 18 h at 291 K with shaking at 160 rev min À1 . Cells were harvested by centrifugation at 5000g for 10 min at 277 K and resuspended in buffer A [25 mM NaH 2 PO 4 /Na 2 HPO 4 pH 7.5, 100 mM NaCl, 14 mM -mercaptoethanol (ME), 1 mM EDTA]. Cells were lysed by cell disruption (Constant Cell Disruption System) and the lysate was centrifuged at 16 000 rev min À1 for 25 min. The supernatant was applied onto an immobilized metal (Ni 2+ ) affinity column (IMAC) pre-equilibrated with buffer A. A linear imidazole gradient (0-1 M) was used to elute the fusion protein. The His 6 tag was cleaved by incubation with recombinant tobacco etch virus (rTEV) protease (overnight at 277 K), after which the rTEV protease and uncleaved protein were removed by a second IMAC step. The cleaved protein retains a Gly-Ser sequence (from the His 6 tag) at the N-terminus of the native GlmU sequence. For final purification, GlmU was concentrated to 20 mg ml À1 and then applied onto a size-exclusion column (Superdex S200 10/30, Pharmacia) equilibrated with buffer A, resulting in a single peak.
Crystallization and data collection
Purified GlmU at a concentration of 10 mg ml À1 in 25 mM NaH 2 PO 4 /Na 2 HPO 4 pH 7.5, 100 mM NaCl, 14 mM ME and 1 mM EDTA was mixed with equal volumes of crystallization buffer from the Top67 crystallization screen (Page et al., 2003) using a Cartesian nanolitre dispensing robot. The sitting-drop vapour-diffusion method was used for crystallizations with 0.2 ml drop volume and 50 ml reservoir volume. Native GlmU crystals grew overnight from 0.2 M magnesium formate and 20% PEG 3350. Crystals of GlmU complexed with UDP-GlcNAc were grown by cocrystallization with 10 mM UDP-GlcNAc, which was included in the protein solution. The crystals were obtained using 9% MPD, 16% ethylene glycol, 5% PEG 8000 and 0.1 M sodium cacodylate as precipitant solution. Crystals of GlmU complexed with GlcNAc-1-P were similarly grown by cocrystallization, with 10 mM GlcN-1-P and 10 mM acetyl-CoA included in the protein solution and 20% PEG 3350 and 0.2 M lithium nitrate as precipitant. The unliganded and GlcNAc-1-P complex crystals grew to maximum dimensions of 50 Â 50 Â 50 mm over three weeks and research papers were difficult to reproduce. In contrast, the UDP-GlcNAc complex crystals grew overnight to maximum dimensions of 500 Â 250 Â 250 mm and were easy to reproduce. The unliganded and GlcNAc-1-P complex crystals were dipped briefly in cryoprotectant (20% ethylene glycol in the reservoir solution) and were flash-frozen in liquid nitrogen prior to data collection. The UDP-GlcNAc complex crystals were directly flash-frozen in liquid nitrogen without any additional cryoprotection prior to data collection. X-ray diffraction data were collected at 110 K on a Rigaku MicroMax007-HR rotatinganode generator with Cu K radiation and MAR345 imageplate detectors, Osmic mirror focusing optics and an Oxford Cryostream system or on Stanford Synchrotron Radiation Laboratory beamline 9-2 equipped with a MAR325 CCD detector. Data-collection statistics are summarized in Table 1 .
Structure determination and refinement
Data were processed in space group H32 using MOSFLM and SCALA (Collaborative Computational Project, Number 4, 1994) . The UDP-GlcNAc complex structure was determined first by molecular replacement using Phaser (Read, 2001; Storoni et al., 2004; McCoy et al., 2005) with S. pneumoniae GlmU (PDB code 1hm9) as the search model. The top solution placed one molecule in the asymmetric unit and this model was completed by several cycles of manual building with Coot (Emsley & Cowtan, 2004) and refinement with REFMAC (Murshudov et al., 1997) . The UDP-GlcNAc molecular structure and geometrical restraints were derived using the Dundee PRODRG2 server (Schü ttelkopf & van Aalten, 2004) . A cacodylate ion was located on a threefold crystallographic rotation axis and refined at 33% occupancy. Solvent molecules were added by automatic peak picking from F o À F c electrondensity maps using Coot. Potential water molecules with electron-density peaks above 3 were selected and were manually checked for appropriate hydrogen-bond geometry in Coot. The final structure was refined using data to 2.5 Å resolution and had an R cryst of 19.5%, an R free of 25.1% and an average B factor of 36.1 Å 2 . The stereochemistry of the final structure was evaluated using MOLPROBITY (Davis et al., 2007) . The Ramachandran plot showed that 96.7% of residues are in the most favoured regions. The final model includes 479 residues (residues 1-479) of the 495 residues in the complete GlmU sequence. The last 16 C-terminal residues were not modelled owing to lack of density. Refinement statistics are summarized in Table  1 . The other two GlmU structures were determined by molecular replacement using the fully refined GlmU-UDP-GlcNAc complex structure as a search model and were refined as above. Electron density was not observed for approximately 100 C-terminal residues in both structures and only residues 2-391 and 2-388 were present in interpretable density for the GlcNAc-1-P complex and unliganded structures, respectively. Refinement statistics are summarized in Table 1 . Figures were prepared using PyMOL (DeLano, 2002) , calculations of rootmean-square differences in atomic positions between different structures were made with SSM (Krissinel & Henrick, 2004) and interfaces were analysed with the EMBL-EBI PISA server (Krissinel & Henrick, 2007) .
Enzyme-activity assays by 1 H NMR
All chemicals were purchased from Sigma. Reactions were carried out in 25 mM potassium phosphate buffer pH 7.5, 50 mM NaCl, 0.5 mM MgCl 2 and 3 mM ME. The acetyltransferase reactions (50 ml Table 1 Data-collection and refinement statistics.
Values in parentheses are for the highest resolution shell. P jF obs j À jF calc j = P jF obs j, where R free was calculated over 5% of amplitudes that were chosen at random and not used in refinement.
UDP-GlcNAc complex
were incubated at 310 K for 45 min, diluted to 1 ml with NMR buffer (25 mM potassium phosphate pH 7.5, 50% D 2 O) and were stored on ice before being brought to room temperature 30 min before NMR spectra were recorded. For assays in the absence of a reducing agent or the presence of a thiolmodifying agent, ME was first removed from GlmU by dialysis. To determine the effect of a thiol-modifying agent, GlmU was incubated for 30 min with 1 mM N-ethylmaleimide prior to the assay. GlmU activity was monitored using onedimensional 1 H NMR spectroscopy. Spectra of reaction solutions were acquired on a DRX 400 spectrometer (Bruker) at 300 K using presaturation of the water resonance (Bax, 1985) . Data were processed using the software XWINNMR 3.0 and TopSpin 1.3 (Bruker).
Results and discussion
Assays of MtGlmU enzymatic activity by 1 H NMR
NMR spectroscopy was used to assay the enzyme activity of MtGlmU. The substrates GlcN-1-P and GlcNAc-1-P and the product UDP-GlcNAc can be readily distinguished from onedimensional 1 H NMR spectra in the region 5.1-5.7 p.p.m. The chemical shifts for many of the protons of the substrates and product are similar. However, the doublet of doublets corresponding to the proton on the anomeric C atom of the glucose moiety is distinctive for each compound. Commercial preparations of the compounds were used to determine that the chemical shift of this proton is 5.55, 5.27 and 5.42 p.p.m. for GlcN-1-P, GlcNAc-1-P and UDP-GlcNAc, respectively, under the conditions of the NMR assay. This signal was used to detect the presence and the relative amounts of substrate and product for each reaction as described below.
3.1.1. Acetyltransferase activity. On incubation of GlcN-1-P and acetyl-CoA with MtGlmU there was a decrease in the signal from the anomeric proton of GlcN-1-P at 5.55 p.p.m. and the appearance of a peak at 5.27 p.p.m. corresponding to GlcNAc-1-P ( Fig. 1a) , confirming acetyltransferase activity. In a control reaction incubated under the same conditions but without MtGlmU, no changes were seen in the spectrum. The acetyltransferase reaction was repeated without MgCl 2 and ME in the enzyme buffer and reaction solution. Under these conditions the enzyme is still able to convert GlcN-1-P to GlcNAc-1-P. The reaction was also carried out in the presence of the thiol-modifying reagent N-ethylmaleimide (NEM) and again no affect on enzyme activity was observed.
We conclude that MtGlmU has acetyltransferase activity in the absence of reducing agent and in the presence of a thiolreactive reagent. This is in marked contrast to EcGlmU, for which the presence of a reducing agent is required for acetyltransferase activity (Pompeo et al., 1998) . Spontaneous inactivation in the absence of reducing agent or inactivation by thiol-specific agents, particularly those with bulky substituents, could occur in the acetyltransferase active site of EcGlmU, specifically at Cys385, which is located within 6 Å of the acetyl-CoA sulfur. Incorporation of bulky thiol-reactive reagents at this site would prevent binding of acetyl-CoA. It is also conceivable that in the absence of reducing agent in vitro acetyl transfer may occur from acetyl-CoA to Cys385, blocking further cofactor binding and inhibiting acetyltransferase function. The three other cysteines within the EcGlmU structure are inaccessible to solvent. Uropathogenic bacteria on urinary catheters are inhibited by various NEM analogues (Burton et al., 2006) and in each case the GlmU acetyltransferase active site contains at least one free cysteine located near the acetyl-CoA sulfur. The MtGlmU structure does not contain a free cysteine in the acetyl-CoA binding site nor any solvent-accessible cysteines elsewhere in the structure.
3.1.2. Uridyltransferase activity. On incubating GlcNAc-1-P and UTP with MtGlmU, a doublet of doublets appeared at 5.42 p.p.m. corresponding to the anomeric proton of UDP-GlcNAc and there was a decrease in the signal from GlcNAc-1-P (Fig. 1b) . This indicates the turnover of GlcNAc-1-P to UDP-GlcNAc and confirms the uridyltransferase activity of MtGlmU. In a control reaction incubated without MtGlmU no change in the spectrum was observed. The uridyltransferase reaction was repeated under the same conditions but without MgCl 2 in the enzyme buffer and reaction solution. In this case turnover to the UDP-GlcNAc product did not occur, confirming that MtGlmU has an absolute requirement for Mg 2+ for uridyltransferase activity.
3.1.3. Overall reaction. In an attempt to couple together the acetyltransferase and uridyltransferase activities of MtGlmU, GlcN-1-P, acetyl-CoA and UTP were incubated with the enzyme. A peak at 5.27 p.p.m. corresponding to the anomeric proton of GlcNAc-1-P was observed, but there was no signal evident at the chemical shift associated with UDP-GlcNAc. Hence, only the initial acetyltransferase reaction was detected and not the second uridyltransferase reaction.
The system was further characterized by incubating the enzyme with acetyl-CoA or GlcN-1-P before addition to the solution containing the uridyltransferase substrates (GlcNAc-1-P and UTP). The uridyltransferase activity was not affected by the presence of GlcN-1-P, whereas in the presence of acetyl-CoA no UDP-GlcNAc was detected. This apparent inhibition of uridyltransferase activity by acetyl-CoA could be the consequence of an allosteric interaction between the active sites. The structural basis of this potential allostery is not apparent from previous crystal structure information nor from the MtGlmU crystal structures described in full below.
Overall structures
Three crystal structures of M. tuberculosis GlmU were determined: an unliganded structure at 2.5 Å resolution, a complex with UDP-GlcNAc at 2.5 Å resolution and a complex with GlcNAc-1-P at 2.75 Å resolution. All three structures belong to space group H32 but with varying unit-cell parameters. The UDP-GlcNAc structure was determined first using molecular replacement and displays unit-cell parameters a = b = 113.99, c = 362.26 Å . The asymmetric unit contains one molecule comprising residues 1-475, with only the final 16 residues (480-495) missing, giving a solvent content of 71% and a V M value of 4.20 Å 3 Da À1 (Matthews, 1968) . The research papers structure shows a GlmU monomer folded into two distinct domains ( Fig. 2a) : an N-terminal domain (residues 2-262) which has a typical uridyltransferase fold based on a dinucleotide-binding Rossmann fold and a C-terminal domain (residues 263-478) which has a left-handed -helix (LH) fold that is characteristic of a number of acetyltransferase enzymes. The unliganded and GlcNAc-1-P structures were determined by molecular replacement using the UDP-GlcNAc coordinates as a search model. Both of these structures contained a single truncated molecule in the asymmetric unit: the final $100 C-terminal residues of each molecule are missing, presumably owing to proteolysis during crystallization. The truncations result in reduced unit-cell parameters, with the unliganded structure having a = b = 94.28, c = 284.31 Å and the GlcNAc-1-P complex structure having a = b = 94.30, c = 288.04 Å . The solvent content and V M of these truncated structures are 55% and 2.76 Å 3 Da À1 , respectively, for the unliganded structure and 56% and 2.80 Å 3 Da À1 , respectively, for the GlcNAc-1-P structure.
Dynamic light scattering (data not shown) and analytical gel filtration show that MtGlmU is trimeric in solution and in the three crystal structures this trimer is produced by a crystallographic threefold axis parallel to the long axis of the monomer (Fig. 2b) . The S. pneumoniae, E. coli and H. influenzae GlmU structures display the same trimer and show root-mean-square differences (r.m.s.d.) in C atomic positions when compared with MtGlmU in the range 1.7-2.5 Å for about 1200 C atoms. The trimer is the biologically functional unit, with the C-terminal acetyltransferase active site containing contributions from all three subunits. The trimer interface is dominated by contacts between the C-terminal -helical domains of the three molecules and buries a total surface of 6320 Å 2 in the truncated unliganded and GlcNAc-1-P structures and of 12 600 Å 2 in the full-length UDP-GlcNAc structure. Although there are some local differences between the three MtGlmU structures, the overall r.m.s.d. for the trimers of the three structures, as calculated by SSM, ranges from 0.6 to 0.8 Å over 1162 C atomic positions and in our discussion below the three structures are treated as equivalent; only significant and unique features of each structure are highlighted.
The left-handed b-helical (acetyltransferase) domain
The C-terminal domain comprises ten repeats (ten coils) of about 18 residues, forming a regular left-handed -helix. Analysis of the reactions catalysed by MtGlmU using 1 H NMR spectroscopy. The change in the chemical shift of the peak corresponding to the anomeric proton of GlcN-1-P (indicated by the asterisks) upon acetylation and uridylation was followed. For GlcN-1-P, GlcNAc-1-P and UDP-GlcNAc the chemical shift of this proton was 5. 55, 5.27 and 5.42 p.p.m., respectively diameter of about 17 Å and is formed by three -strands with a distinctive repetitive pattern of hydrophobic residues. The interior of the helix is predominantly hydrophobic, with stacks of aliphatic or aromatic residues. The result is a long narrow channel coincident with the helix axis, measuring 2-3 Å in diameter from which solvent is excluded. The UDP-GlcNAc structure contains a cacodylate ion located on the threefold trimer axis and coordinated by Arg323 and its two symmetryrelated equivalents.
All attempts to cocrystallize or soak crystals of MtGlmU with acetyl-CoA, CoA or analogues were unsuccessful, but given the high degree of sequence and structural similarity of known GlmU proteins these molecules should bind in a similar way to that seen in the other GlmU structures, i.e. research papers Figure 2 Structure of M. tuberculosis GlmU. (a) Monomer of the UDP-GlcNAc complex. The protein is shown as a cartoon model and is colour-ramped from blue (N-terminus) to green (C-terminus). The UDP-GlcNAc and cacodylate molecules are drawn as space-filling models. The site of C-terminal truncation in the unliganded and GlcNAc-1-P structures is indicated by an asterisk. (b) The trimeric structure of MtGlmU as produced by applying threefold crystallographic symmetry. Acetyl-CoA is modelled into the acetyltransferase active site by comparison to an E. coli GlmU structure and is drawn as a space-filling model. (c) Close-up view of the acetyltransferase active site. The active site is formed between two adjacent LH domains, the insertion loop and the domain-swapping C-terminal extension from the third molecule of the trimer. A structure-based sequence alignment is shown for M. tuberculosis, S. pneumonia and E. coli GlmU proteins. MtGlmU has an additional 24 amino acids in its C-terminal extension, some of which form helix 9 and additional interactions with the LH domain of one monomer.
within the trimeric LH assembly between pairs of adjacent domains (Olsen & Roderick, 2001; Sulzenbacher et al., 2001; Olsen et al., 2007) . The cofactor-binding site is delineated by the outer faces of two adjacent LH domains, including an external loop that interrupts the eighth helical coil of one domain and by the domain-swapped C-terminal tail of the third molecule of the trimer (Fig. 2c) . The external loop of the eighth helical repeat (residues 395-405) is the site of truncation in the unliganded and GlcNAc-1-P structures. The propensity of this site for proteolytic cleavage may be suggestive of a regulatory role; MtGlmU acetyltransferase activity may be downregulated by protein degradation under proteolytic conditions or in response to a cellular signal.
The final part of the MtGlmU C-terminal extension comprises two -helices, 8 (459-466) and 9 (469-479), which are linked by a series of -turns (Fig. 2c ). This arrangement buries residues Trp460, Val461, Ala470 and Ala473 both internally within the helix-turn-helix section and within the C-terminal extension-LH interface. An additional interaction between Gln462 OE1 and the peptide N atom of Ser474 further links and stabilizes the topology of these final two helices. As revealed in a multiple structure-based sequence alignment (Fig. 2c) , the domain-swapping C-terminal extension is longer than in the E. coli and S. pneumoniae GlmU structures and provides additional stability to the biological trimer and the acetyl-CoA-binding site. In the 8 region of the domainswapping arms, the structures of all three species contain arginine or lysine residues equivalent to MtGlmU Arg463 that bind the 3 0 ribosyl phosphate of acetyl-CoA; beyond this the structures diverge.
Uridyltransferase domain
The MtGlmU uridyltransferase-domain structure is very similar to that reported for S. pneumoniae (SpGlmU), with an overall r.m.s.d. in 228 C positions of 1.1 Å between the pair of UDP-GlcNAc structures. The unliganded MtGlmU structure displays a more closed conformation in the GlcNAc-binding site than in any other known unliganded GlmU structure. Analysis of the crystal packing in the MtGlmU structure suggests that an open structure in the absence of substrate is disfavoured by intermolecular crystal contacts. The binding mode for UDP-GlcNAc in the active site of MtGlmU matches that seen for SpGlmU very closely, with the UDP-GlcNAc molecule, the final product of the reaction, making the same contacts to conserved amino-acid residues. When the two protein structures are superimposed, the UDP-GlcNAc molecules superimpose equally well, with an r.m.s.d. of 0.84 Å for the 39 ligand atoms. The only notable difference is that no Mg 2+ ion is observed in the MtGlmU active site.
The novel GlcNAc-1-P structure unambiguously defines the binding site for this ligand and identifies an extensive network of hydrogen bonds between its various oxygen groups and residues of the active-site cavity (Fig. 3a) . Thus, the acetyl O atom (O7 0 ) of the N-acetyl group forms a hydrogen bond to Thr89 OG1 (2.9 Å ) and the glucose O3 hydroxyl group forms hydrogen bonds to Glu166 OE2 (2.4 Å ) and the side-chain amido N atom (ND2) of Asn181 (2.8 Å ). The O4 hydroxyl also forms two hydrogen bonds to the peptide NH of Gly151 (2.9 Å ) and the peptide O of Asn181 (2.6 Å ). A phosphate O atom forms a water-mediated hydrogen bond to Asp114. It is possible that the water molecule involved in this interaction is actually an Mg 2+ cation that would effectively balance the negative phosphate charge; however, the bond distances and geometry do not allow us to distinguish between a water and Mg 2+ in this site. The carboxyl O atoms (OE1 and OE2) of Asp114 also hydrogen bond to Ser112 OG and Lys22 NZ, respectively. All these residues are highly conserved within the M. tuberculosis, E. coli, H. influenzae and S. pneumoniae GlmU sequences.
The GlcNAc-1-P substrate clearly binds in a very similar way to the UDP-GlcNAc
